Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy
- PMID:19098873
- DOI: 10.1038/ajg.2008.71
Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy
Abstract
The introduction of biologic therapy with therapeutic monoclonal antibodies to the treatment strategies of inflammatory bowel disease (IBD) has significantly changed the way clinicians practice. Antibodies are cleared differently than small molecules, and knowledge about the pharmacology and immunology of immunoglobulins is helpful when using these agents in women preconception and during pregnancy. The most commonly used antibody therapies in patients with IBD are IgG1 molecules, but others are under development. When treating patients who are pregnant or contemplating pregnancy, it is important to remember that immunoglobulin G (IgG) is the predominant means of fetal immunity and that it is transported across the placenta. This transport happens in a linear fashion as the pregnancy progresses, with the largest amount transferred in the third trimester. Preferential transport occurs for IgG1, followed by IgG4, and IgG3, with IgG2 being the least detected. Understanding the mechanism for immunoglobulin transfer will help to understand how to minimize risk of exposure of the fetus to the therapeutic monoclonal antibody both in utero and after delivery.
Similar articles
- Medical management of the pregnant patient with inflammatory bowel disease.Steinlauf AF, Present DH.Steinlauf AF, et al.Gastroenterol Clin North Am. 2004 Jun;33(2):361-85, xi. doi: 10.1016/j.gtc.2004.02.013.Gastroenterol Clin North Am. 2004.PMID:15177544Review.
- An interspecies comparison of placental antibody transfer: new insights into developmental toxicity testing of monoclonal antibodies.Pentsuk N, van der Laan JW.Pentsuk N, et al.Birth Defects Res B Dev Reprod Toxicol. 2009 Aug;86(4):328-44. doi: 10.1002/bdrb.20201.Birth Defects Res B Dev Reprod Toxicol. 2009.PMID:19626656Review.
- High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy.Zelinkova Z, de Haar C, de Ridder L, Pierik MJ, Kuipers EJ, Peppelenbosch MP, van der Woude CJ.Zelinkova Z, et al.Aliment Pharmacol Ther. 2011 May;33(9):1053-8. doi: 10.1111/j.1365-2036.2011.04617.x. Epub 2011 Mar 1.Aliment Pharmacol Ther. 2011.PMID:21366638
- Effects of nicotine-specific antibodies, Nic311 and Nic-IgG, on the transfer of nicotine across the human placenta.Nekhayeva IA, Nanovskaya TN, Pentel PR, Keyler DE, Hankins GD, Ahmed MS.Nekhayeva IA, et al.Biochem Pharmacol. 2005 Nov 25;70(11):1664-72. doi: 10.1016/j.bcp.2005.08.013. Epub 2005 Oct 11.Biochem Pharmacol. 2005.PMID:16223470
- A Narrative Review on Anti-Tumor Necrosis Factor α Therapies in Inflammatory Bowel Disease During Pregnancy: Immunoglobulin Placental Translocation and its Impact.Roseira J, Ramos J.Roseira J, et al.Acta Med Port. 2019 Apr 30;32(4):305-312. doi: 10.20344/amp.11482. Epub 2019 Apr 30.Acta Med Port. 2019.PMID:31067425Review.
Cited by
- Transfer of monoclonal antibodies into breastmilk in neurologic and non-neurologic diseases.LaHue SC, Anderson A, Krysko KM, Rutatangwa A, Dorsey MJ, Hale T, Mahadevan U, Rogers EE, Rosenstein MG, Bove R.LaHue SC, et al.Neurol Neuroimmunol Neuroinflamm. 2020 May 27;7(4):e769. doi: 10.1212/NXI.0000000000000769. Print 2020 Jul.Neurol Neuroimmunol Neuroinflamm. 2020.PMID:32461351Free PMC article.
- Product review on MAbs (alemtuzumab and ocrelizumab) for the treatment of multiple sclerosis.Gabelić T, Barun B, Adamec I, Krbot Skorić M, Habek M.Gabelić T, et al.Hum Vaccin Immunother. 2021 Nov 2;17(11):4345-4362. doi: 10.1080/21645515.2021.1969850. Epub 2021 Oct 20.Hum Vaccin Immunother. 2021.PMID:34668842Free PMC article.
- Clinical therapeutics in pregnancy.Feghali MN, Mattison DR.Feghali MN, et al.J Biomed Biotechnol. 2011;2011:783528. doi: 10.1155/2011/783528. Epub 2011 Jul 6.J Biomed Biotechnol. 2011.PMID:21785566Free PMC article.
- Utilisation et incidence des agents biologiques à base d’anticorps monoclonaux durant la grossesse.Pham-Huy A, Top KA, Constantinescu C, Seow CH, El-Chaâr D.Pham-Huy A, et al.CMAJ. 2021 Oct 4;193(39):E1537-E1544. doi: 10.1503/cmaj.202391-f.CMAJ. 2021.PMID:34607850Free PMC article.Review.French.No abstract available.
- Maternal but Not Infant Anti-HIV-1 Neutralizing Antibody Response Associates with Enhanced Transmission and Infant Morbidity.Ghulam-Smith M, Olson A, White LF, Chasela CS, Ellington SR, Kourtis AP, Jamieson DJ, Tegha G, van der Horst CM, Sagar M.Ghulam-Smith M, et al.mBio. 2017 Oct 24;8(5):e01373-17. doi: 10.1128/mBio.01373-17.mBio. 2017.PMID:29066544Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical